chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 weeks after the second dose she started to have dizziness; 4 weeks after the second dose she started to have a couple episodes of vertigo which has continued to today.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (4 weeks after the second dose she started to have dizziness) and VERTIGO (4 weeks after the second dose she started to have a couple episodes of vertigo which has continued to today.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 017A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced DIZZINESS (4 weeks after the second dose she started to have dizziness) and VERTIGO (4 weeks after the second dose she started to have a couple episodes of vertigo which has continued to today.). At the time of the report, DIZZINESS (4 weeks after the second dose she started to have dizziness) and VERTIGO (4 weeks after the last dose she started to have a couple episodes of vertigo which has continued to today.) had not resolved.            No concomitant medications were reported No treatment medications were reported  Symptoms: It was reported that 4 weeks post second dose vaccination, patient started experiencing dizziness and vertigo episodes, which was aggravated by actions like standing up, thrown her head back to take medicines and when her eyes were closed, she tried to slow her actions and became deliberate which helped some level.She has spoken to a doctor regarding her dizziness, who encouraged her to wait it out.   This case was linked to MOD-2021-399922 (Patient Link).
A Moderna vaccine vial was taken out of an expired box that was sequestered in the fridge (expiration date 10/10/21; previously kept because of a potential extension in shelf life). A single dose was drawn from the vial and administered to a patient as a booster dose (patient previously had two doses of Moderna). The manufacturer was contacted for the next steps and this error was reported in formal writing to the pharmacy manager. The representative from Moderna informed us this case would be sent to the Medical Affairs director and we would receive a response within a few business days. After VAERS reporting, we will decide how and what information to convey to the patient being involved and contact the patient.
Initial case was received from a healthcare professional on 03 February 2014.  A 41-year-old male patient had medical history of allergic to iodine and shell fish, with no concomitant medication reported had received FLUZONE intramuscularly on left deltoid 23 January 2014 (batch number UH895AA). It was reported that on 25 January 2014 patient developed red patches on her neck, chest, stomach, arms, and back and experienced extremely itchy. No laboratory investigation and corrective treatment ws reported. At the time of report outcome of the event was recovered. Lit of documents held by sender: none
Pain in the arm along the inside from the shoulder to fingers. Pain down the inner side of the leg. Both on left side only. Occuring starting within 10 minutes of the shot. Later, extreme fatigue and tiredness for about 36 hours.  Continuing dull/throbbing/aching in the muscle of my inner left quad from the hip to knee. This has been persistent since the first dose. Feels like an over-exercised/pulled muscle. No physical exertion event occurred to precipitate this condition.
Patient received Pfizer vaccine and during observation began to feel dizzy. Patient was transported to the ED. She had a hypertensive response associated with mild chest discomfort. after initial hypertensive response B/P trended downward. EEG negative for STEMI or ST abnormality. Observed in ED and discharged in stable condition.
Blood pressure crashed I assume. About five minutes after got hot and sweaty and felt nauseous. Wanted to pass out, throw up and rip off my clothes.Then rapid breathing. And more hot and sweaty snd shaky. And then my hands went numb and stiff. And then my lips turned blue/grey and my face went white. They couldn?t register my pulse ox and it wouldn?t register on my watch for awhile.  Things improved and I was cold and shaky. About half an hour to 45 minutes after the shot I got better and was allowed to leave an hour after the shot. Was very tired and went home to sleep for a few hours. Did not appear to be allergic no itching, rashing, or swelling, or throat closing. The site monitored me and I drank sips of water and reclined my chair and ran the AC full. I don't think they were equipped to handled adverse responses. So far I'm ok other than the feeling like I have the flu from the vaccine feelings
Chills; Fever; Bad Headache; Vomiting; Diarrhea; Body aches; Loss of appetite; This is a spontaneous report from a contactable Other Health Professional (patient). A 50-Years-old female (No Pregnancy) patient received 2nd dose of BNT162B2 (lot number= EW0179) on 30Apr2021 03:15 PM on Right arm for Covid-19 Immunization. Medical history was allergies: Penicillin. No other vaccine in four weeks. Other medications in two weeks was Daily Multi Vitamins. Historical Vaccine was 1st dose of BNT162B2 (lot number= ER8729) on 09Apr2021 01:30 PM on Right arm for Covid-19 Immunization. Patient experienced Chills, Fever, Bad Headache, Vomiting, Diarrhea, Body aches, Loss of appetite from 01May2021 03:00 AM with outcome was Recovering. Treatment: Tylenol and Ibuprofen. No covid prior vaccination, no covid test post vaccination.  No follow-up attempts are needed. No further information is expected.
Within 24 hours of booster, my father was unable to support himself alone with his walker, needing a 2-person assist. His breathing was labored after moving only a few steps. We had to use a wheelchair to transport him in the home. He complained of pain in his right hip to his ankle. My father became very fearful (full anxiety) that he was going to fall when we tried to stand him to get on the toilet or change his position. His right leg would not initiate in movement. We had to push his foot forward to move it. Later, we had him try to initiate a step with his left foot which did not seem as impaired. He became much less talkative and seemed very "distant".  His eyes did not track as well as before.
Began to feel facial tingling and numbness 3 minutes post vaccination; "things started spinning and vision was blurry"; nausea-began having dry heaves (had not eaten), CBG 123, HR bradycardic and erratic, developed pounding HA, EMT stated "throwing PVCs"; then went to ER in POV
Initial information has been received from a physician via a company representative and follow-up information has been received from the physician concerning a 14 year old female student who, on 20-NOV-2006, was vaccinated with a 0.5 ml dose of Gardasil (yeast) (lot# not reported). There was no concomitant medication. Subsequently, on approximately 22-NOV-2006 or 23-NOV-2006, the patient developed a bad acne breakout. The physician reported that the patient developed "giant pimples" the likes of which she'd not experienced previously. The patient was reported to have been using over the counter acne wash which had been working well up to this point. The patient was put on oral antibiotics and given a topical wash for the breakout, which occurred on her face, chest and back. The patient's acne breakout was continuing at the time of the report. Additional information has been requested.
Sudden onset of menstral cycle 1 week early witch much more severe symptoms. Heavier bleeding, severe cramping, nausea, causing missing work.
Immunization site W/major reaction. Non-pruritic distinct papular eruption on trunk and proximal upper extremities no pustules, palms/face clear.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 14-JAN-2015, the patient was inoculated  with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended at physician's office for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after receiving the ZOSTAVAX vaccine, the patient developed itching and redness in her left eye. Thereafter, the patient was diagnosed with vision complications, including severe vision loss, in both eyes. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, severe vision loss in both eyes was determined to be medically significant. Additional information has been requested.
Pt reports redness, swelling and tenderness to touch in (R) arm (Deltoid area), S/S started day after receiving vaccines in that arm, S/S decreasing with time using Ibuprofen and Ice.
vasovagal syncope within 4-5 minutes of receiving injection.  Fell from standing position face first to the floor.  "Thankfully", his little sister had already passed out from her vaccination and the nurse and I were helping her on the floor so we broke his fall or it could have been a very serious fall. As with his sister, there were no warning signs before he passed out, no dizziness or nausea or feeling ill, he simply said he saw everything go black and he hit the floor, while he was out his muscles twitched uncontrollably, his blood pressure stayed low for a considerable time after regaining consciousness- 10 minutes after it was at 90/50, he was drenched in sweat and very pale.  He took more than 45 minutes before he could stand up and was shaky for a number of hours afterward.  As with his sister, who received a different injection, I was concerned with the similarities in the two vaccinations--but the doctors refused to consider the vaccinations as having anything to do with it, insisting he passed out because out of sympathy due to watching his sister pass out.  The doctor's office refuses to consider ANYTHING other than my children panicking and not even being aware of it themselves or me being aware of it as their mother.  I know my children and that was NOT the case.   There is something about these vaccines that caused my children to have a very serious reaction and we are just lucky that their falls did not cause serious injury.
25MAY98 noticed rash on legs;then rash moved to abd, chest & back;no fever or decrease in activity;28MAY98 mom brought pt to clinic had large area of confluent red raised rash on abd, chest, & back;T98.8;
Information has been received from a nurse practitioner concerning an 83 year old male with no pertinent medical history who on 03-JUL-2007 was vaccinated with a 0.65ml SC dose of ZOSTAVAX. On 14-JUL-2007 the patient developed shingles. Patient was sent to urgent care. The patient was prescribed VALTREX (manufacturer unknown). No labs were performed. The patient was noted to be recovering. No product quality complaint reported. Additional information has been requested.
Patient hospitalized for vaginal delivery within 6 weeks of receiving covid vaccination. Birth weight of baby was 7 pounds 4.8 ounces.
one week later the patient had a large red circle that was extremely itchy and warm.  It does not hurt.
The patient report that an expired dose of PNEOMUVAX 23 was administered; This spontaneous report has been received from a pharmacist concerning to a patient of unknown age.      The patient's concurrent conditions, medical history and concomitant medication were not reported.  On 30-JUL-2021 (also reported as "today"), the patient was vaccinated with first dose of an expired vaccine of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot # S027979 has been verified to be valid, expiration date 30-MAY-2021) (anatomical location was not reported) for prophylaxis. Moreover, the reporter stated that pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was properly stored up through administration, with no temperature excursiones. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: S027979; expirationdate: 30-MAY-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
got real sick couldn't move for about 24hrs after shot, whole body was hurting, 2wks later knees got real stiff and she started physical therapy
I have a large 1  1/2  inch diameter red ..slightly swollen but hot to touch.  It itches and seems harder than other parts of my arm.
Developed a red, warm and swollen area approx 2" diameter at site of injection in right deltoid. Pt complained of itching at site also. Warm moist packs applied. Shot was given on 8/13/03, pt reported per phone on 8/14/03. Arm was checked on 8/15/03 and area was >2" and much better.
Afftected is hearing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Afftected is hearing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOACUSIS (Afftected is hearing). At the time of the report, HYPOACUSIS (Afftected is hearing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment information not reported.
immed local rxn, lt deltoid w/redness & swelling; discussed by phone w/MD; advised DPH;
Client scheduled for Pfizer appointment and received it after incorrectly reporting they were 16 years old or older. Client is 15 and Pfizer will be approved for 12-15 year old shortly, so will remain on invitation list.
got the COVID-19 vaccine last week and six days later tested positive for COVID-19; got the COVID-19 vaccine last week and six days later tested positive for COVID-19; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gender received bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not reported), via an unspecified route of administration on unspecified date in Dec2020 at single dose, for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got the covid-19 vaccine last week and six days later (Dec2020) tested positive for Covid-19. The outcome of event was unknown.  Information about Lot/Batch number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.
Patient fainted after receiving 1st dose of Moderna.  He recovered after about 20 seconds.  Pharmacist checked blood pressure several times and it was within normal limits.  After 45 minutes of observation patient felt ok to go home.  Pharmacy called an car service to take patient home since he walked to the store alone.
DRUG EXPOSURE VIA BREAST MILK; This spontaneous report received from a consumer concerned an infant of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient's parent received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced drug exposure via breast milk. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of drug exposure via breast milk was not reported. This report was non-serious. This parent/child case is linked to 20210818073.
Severe rash all over upper right arm started on 11/1/18 around 330pm. Upper arm swelling and severe pain occurred. Patient used ice pack and ADVIL for treatment. Symptoms started to resolve by Friday evening.  Rash seems fully recovered (only slight redness) on 11/3/18 but patient still have mild pain at injection site as of 12:28pm.
Body aches; Chills; Low grade temp; Tired; This is a spontaneous report from a contactable healthcare professional. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 10:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had an unspecified allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 23:00, the patient experienced body aches, chills, low grade temperature and felt tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, chills, low grade temperature and felt tired were resolved on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient had a seizure hours after vaccination. Patient was very stressed and dehydrated and has had a history of seizure once before
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 as dose 5 (booster), single (Lot number: GH9693) at the age of 64 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 20Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 10Apr2021 as dose 2, single (Lot number: EW015), on 29Oct2021 as dose 3 (booster), single (Lot number: EW0217) and on 18Apr2022 as dose 4 (booster), single (Lot number: FK9894) for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "depression" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing); "GERD" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN, start date: Jan2011; FAMOTIDINE, start date: Jan2018; ALENDRONATE, start date: Jan2022. Past drug history included: Citalopram, reaction(s): "known allergies: citalopram". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid treatment from 30Mar2023 to 04Apr2023.
Pt received immunization at 1700 on 2/13/07.  Called into office on 22/20/07 c/o left arm pain.  Physical exam showed a raised, red, warm rash. 3" x 3" inches, semi-circular pattern. Pt stated it started bothering her 2 days ago
Information has been received from a nurse practitioner concerning a 6 year old male with no known drug allergies or medical history who on 16Dec1999 was vaccinated with a dose of varicella virus vaccine live. On 20Feb2004 the pt presented to a school nurse with a mild case of chickenpox. Unspecified medical attention was sought. It was noted that the school in this county had an outbreak of chickenpox. No product quality complaint was involved. It was also reported that 2 additional children were vaccinated with a dose of varicella virus vaccine live and developed a mild case of chickenpox. No additional information was available.
patient got a sinus infection; Initial information was received on 05-Jan-2021 regarding an unsolicited valid non-serious case from a consumer/non-health care professional (patient) via social media.   This case involves a patient of unknown age who got a sinus infection (sinusitis), while patient received vaccine INFLUENZA VACCINE.  Medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) it was reported that patient got a flu shot 7 years ago, never been so sick in patients life. Had not got a flu shot since and had not been that sick since. Use to never get sick in the fall or spring until the stupid shot, now ever year around the fall and spring patient got a sinus infection (sinusitis).  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  Information on lot number was requested for this case.
coughing; allergies; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER COVID 19 VACCINE; formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 21May2021 as 2ND DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 26May2021 the patient experienced coughing and allergies. She wants to know if she can take over-the-counter medication for allergies. The outcome of the events was not recovered.  Follow-up attempts are needed; information about lot/batch number cannot be obtained.
Swelling, redness and pain in the left arm, started 1/20/21, 9 days post-injection. Nausea, stomach pain started 1/20/21. Sty in eye plus sinus pressure and drainage started 1/19/2021 in the afternoon.